La nuova BBS è in fase Alpha. I post precedenti al 22 luglio 2024 potrebbero non essere trasferibili, ma rimarranno disponibili per la lettura su /old/.
Gilead has announced that lenacapavir, the game-changing HIV prevention drug just approved by the FDA will cost $28,218 USD per person per year.
-
Gilead has announced that lenacapavir, the game-changing HIV prevention drug just approved by the FDA will cost $28,218 USD per person per year.
Researchers say a generic version could be made for just $25 per person a year.
Capitalism kills.
-
D dunpiteog@devianze.city shared this topic on
